Centessa Pharmaceuticals

NASDAQ: CNTA · Real-Time Price · USD
17.92
0.28 (1.59%)
At close: Aug 15, 2025, 1:21 PM

Centessa Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-8.13 -5.07 -1.34 -95.03
PEG Ratio
-0.26 0.16 0.03 -0.02
PS Ratio
n/a 111.71 n/a n/a
PB Ratio
4.78 3.24 0.86 2.06
P/FCF Ratio
-13.49 -4.77 -1.44 -7.43
P/OCF Ratio
-13.5 -4.77 -1.44 -7.44
OCF/S Ratio
n/a -23.4 n/a n/a
Debt / Equity Ratio
0.29 0.36 0.21 0.15
Quick Ratio
9.25 8.00 11.05 24.88
Current Ratio
9.25 8.00 10.27 24.15
Asset Turnover
n/a 0.02 n/a n/a
Interest Coverage
-19.92 -17.29 -30.18 -4.1
Return on Equity
-0.59 -0.64 -0.64 -0.02
Return on Assets
-0.41 -0.42 -0.49 -0.02
Return on Invested Capital
-0.39 -0.46 -0.52 -0.02
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 1.00 n/a n/a
Net Profit Margin
n/a -22.05 n/a n/a
Pretax Profit Margin
n/a -25.7 n/a n/a
Operating Profit Margin
n/a -24.99 n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -24.23 n/a n/a